Why the growth investor may take a look at NYSE:BMA.

Groth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if BANCO MACRO SA-ADR (NYSE:BMA) is suited for growth investing. Investors should of course do their own research, but we spotted BANCO MACRO SA-ADR showing up in our CANSLIM growth screen, so it may be worth spending some more time on it.

Some of the canslim metrics of NYSE:BMA highlighted

• In the most recent financial report, BANCO MACRO SA-ADR reported a 3.0K% increase in quarterly earnings compared to the previous quarter. This notable growth indicates positive momentum in the company's financials, suggesting an upward trend
• BANCO MACRO SA-ADR has achieved 668.0% growth in its revenue over the previous quarter, signaling positive momentum in its financial performance and potential market opportunities.
• BANCO MACRO SA-ADR has achieved 170.0% growth in EPS over the past 3 years, reflecting a sustained improvement in earnings performance.
• With a solid Return on Equity (ROE) of 25.68%, BANCO MACRO SA-ADR exemplifies its ability to generate favorable returns on shareholder investments. This metric demonstrates the company's commitment to maximizing shareholder value.
• The Relative Strength (RS) of BANCO MACRO SA-ADR has been consistently solid, with a current 97.14 rating. This highlights the stock's ability to exhibit sustained price strength and signifies its competitive advantage. BANCO MACRO SA-ADR exhibits strong prospects for further price appreciation.
• BANCO MACRO SA-ADR maintains a healthy Debt-to-Equity ratio of 0.14. This indicates the company's conservative capital structure and signifies its ability to effectively manage debt obligations while maintaining a strong equity position.
• BANCO MACRO SA-ADR exhibits a favorable ownership structure, with an institutional shareholder ownership of 6.45%. This signifies a diverse investor base, which can contribute to a more stable and efficient market for the stock.

Deciphering the Technical Picture of NYSE:BMA

ChartMill assigns a Technical Rating to every stock. This score ranges from 0 to 10 and is updated daily. The score is determined by evaluating multiple technical indicators and properties.

We assign a technical rating of 6 out of 10 to BMA. In the last year, BMA was one of the better performers, but we do observe some doubts in the very recent evolution.

• Looking at the yearly performance, BMA did better than 97% of all other stocks.
• BMA is part of the Banks industry. There are 410 other stocks in this industry. BMA outperforms 100% of them.
• BMA is currently trading in the upper part of its 52 week range. The S&P500 Index however is currently trading near a new high, so BMA is lagging the market slightly.
• The short term trend is negative, but the long term trend is still positive. So although the long term is still positive, this may be a trend turning.

Our latest full technical report of BMA contains the most current technical analsysis.

Fundamental analysis of NYSE:BMA

As part of its analysis, ChartMill provides a comprehensive Fundamental Rating for each stock. This rating, ranging from 0 to 10, is updated on a daily basis and is based on the evaluation of various fundamental indicators and properties.

BMA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 410 industry peers in the Banks industry. Both the profitability and financial health of BMA have multiple concerns. BMA shows excellent growth, but is valued quite expensive already.

Our latest full fundamental report of BMA contains the most current fundamental analsysis.

More growth stocks can be found in our CANSLIM screen.

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.